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Abstract
OBJECTIVES: Patients undergoing major surgery are at increased risk of developing infections due to resistant organisms, including
carbapenem-resistant Klebsiella pneumoniae (CR-Kp). In this study, we assessed risk factors for CR-Kp infections after open heart surgery in
a teaching hospital in northern Italy.
METHODS: A retrospective study was conducted from January to December 2014. The primary outcome measure was postoperative
CR-Kp infection, defined as a time-to-event end-point. The effect of potentially related variables was assessed by univariable and multi-
variable analyses. Secondary end-points were in-hospital mortality and 180-day postoperative mortality.
RESULTS: Among 553 patients undergoing open heart surgery, 32 developed CR-Kp infections (6%). In the final multivariable model, CR-Kp col-
onization [hazard ratio (HR) 227.45, 95% confidence intervals (CI) 67.13–1225.20, P < 0.001], cardiopulmonary bypass time in minutes (HR 1.01,
95% CI 1.01–1.02, P < 0.001), chronic obstructive pulmonary disease (HR 3.99, 95% CI 1.61–9.45, P = 0.004), SOFA score (HR 1.29, 95% CI 1.08–1.53,
P = 0.007), preoperative mechanical ventilation (HR 8.10, 95% CI 1.31–48.57, P = 0.026), prolonged mechanical ventilation (HR 2.48, 95% CI 1.08–
6.15, P = 0.032) and female sex (HR 2.08, 95% CI 1.00–4.36, P = 0.049) were associated with the development of CR-Kp infection. Increased
in-hospital mortality and 180-day mortality were observed in patients who developed CR-Kp infections in comparison with those who did not.
CONCLUSIONS: In our cohort, CR-Kp colonization was an important predictor of CR-Kp infection after open heart surgery. CR-Kp infection
after surgery significantly affected survival. Preventing colonization is conceivably the most effective current strategy to reduce the impact of
CR-Kp.
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INTRODUCTION
The number of hospital outbreaks caused by carbapenem-resistant
Klebsiella pneumoniae (CR-Kp) has rapidly increased in recent years,
and CR-Kp is now considered endemic in several countries, includ-
ing Italy [1]. The global spread of this pathogen is a matter of
concern because of the shortage of therapeutic options and the im-
pressive mortality associated with CR-Kp infections, which has been
reported to be as high as 40–60% [2, 3]. From a pathogenic stand-
point, CR-Kp infections are mostly preceded by colonization of the
bowel flora, although they may also follow colonization or contam-
ination of different body surfaces and devices [4].
Patients undergoing major surgery are at increased risk of devel-
oping CR-Kp infections in comparison with other patient populations
[4–6]. In this regard, identifying risk factors for CR-Kp infection might
be crucial to prevent the disease and reduce morbidity and mortality
in the postoperative period. However, while the pivotal role of
underlying diseases and former healthcare contacts in influencing
the risk of CR-Kp infection has been extensively recognized [4, 5], few
data exist on unique risk factors for postoperative CR-Kp infection by
surgical specialty [6, 7].
The aim of the present study was to assess risk factors for CR-Kp
infections after cardiac surgery in a large teaching hospital in nor-
thern Italy, as well as to describe the related postoperative mortality.
MATERIAL ANDMETHODS
A single-centre retrospective study was conducted at the IRCCS
AOU San Martino-IST teaching Hospital, University of Genoa,†These authors contributed equally.
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Genoa, Italy. From January 2014 to December 2014, all patients
who underwent open heart surgery were included in the study.
The primary outcome measure was postoperative CR-Kp infec-
tion, defined as a time-to-event end-point (with origin set at the
time of surgery). Secondary end-points were (i) crude in-hospital
mortality and (ii) 180-day postoperative mortality.
Medical charts and laboratory databases were reviewed to
collect demographic, clinical and microbiological data. Survivors
were followed for at least 180 days after surgery, including daily as-
sistance in intensive care unit (ICU), surgical wards and rehabilita-
tion wards, and scheduled out-patient visits every 3 months after
discharge.
Definitions
CR-Kp infection was defined and classified according to the
Centers for Disease Control and Prevention (CDC) criteria [8]. For
the purpose of this study, only the first CR-Kp infection episode
after cardiac surgery was considered for the analysis. Identification
of CR-Kp from rectal swab in the absence of signs and symptoms
of infection was defined as CR-Kp colonization [7].
For all the patients, routine surveillance rectal swabbing was
performed at standard points in time: (i) before surgery and (ii)
the first day after surgery and every 7 days thereafter until dis-
charge. According to the time of the first positive culture, isolation
of CR-Kp from rectal swab was categorized as pre-surgery (i) or
post-surgery (ii) CR-Kp colonization.
Data collected for the analysis
The following variables were evaluated as potential risk factors for
CR-Kp infection after cardiac surgery: age; gender; body surface area
(BSA); preoperative length of stay in days; preoperative New York
Hearth Association (NYHA) class; hypertension; diabetes mellitus
(defined as oral antihyperglycaemic therapy or insulin intake); obesity
[defined as body mass index (BMI) ≥30 kg/m2]; smoking (defined as
current smoking); dyslipidaemia [defined as one or more of the fol-
lowing: triglyceride (TG) ≥200 mg/dl, high-density lipoprotein choles-
terol (HDL-C) <40 mg/dl, total cholesterol (TC)/HDL-C ratio ≥4, TG/
HDL-C ratio ≥3.8, low-density lipoprotein cholesterol (LDL-C)/HDL-C
ratio ≥2.5]; chronic kidney disease (defined as baseline serum creatin-
ine >200 µmol/l); chronic obstructive pulmonary disease (COPD,
defined as long-term use of bronchodilators or steroids for lung
disease); extracardiac arteriopathy (defined as one or more of the fol-
lowing: claudication; carotid occlusion or >50% stenosis; amputation
for arterial disease; previous or planned intervention on the abdomin-
al aorta, limb arteries or carotids); history of cerebrovascular accident;
previous myocardial infarction; Charlson comorbidity index [9]; base-
line left ventricular ejection fraction (LVEF); requirement of preopera-
tive mechanical ventilation; history of immunosuppression [defined as
one or more of the following: HIV infection; solid organ transplant-
ation; malignancy; neutropenia (absolute neutrophil count <1000
cells/mm3); therapy with at least 10 mg of prednisone or its equivalent
per day for >14 days prior to surgery; chemotherapy within 45 days
before surgery]; European System for Cardiac Operative Risk
Evaluation II (EuroSCORE II); full sternotomy; type of surgery [categor-
ized as isolated coronary artery bypass surgery, isolated valvular
surgery, surgery of thoracic aorta and other procedures (including
combined procedures, pericardiectomy and surgery for cardiac
tumours)]; surgical priority (urgency/emergency versus scheduled);
cardiopulmonary bypass (CPB) time in minutes; aortic cross-clamp
time in minutes; need for intraoperative blood transfusion; Sequential
Organ Failure Assessment (SOFA) score immediate after surgery; pro-
longed mechanical ventilation (defined as postoperative mechanical
ventilation >48 h); CR-Kp colonization. The following descriptive data
were also recorded: postoperative stroke (defined as cerebrovascular
accident with symptoms lasting more than 24 h with or without
residual disability, confirmed at computed tomography or magnetic
resonance imaging; in the case of no evidence of stroke at
neuro-imaging, the diagnosis of stroke was made by consultant neu-
rologists); pacemaker implantation; reoperation for bleeding; length
of postoperative ICU stay in days; length of postoperative hospital stay
in days.
Microbiology
The Vitek 2 automated system (bioMérieux, Marcy l’Etoile, France)
was used for the identification of Kp isolates and for antimicrobial
susceptibility testing. The interpretative breakpoints for carbapenem
resistance were based on the European Committee on Antimicrobial
Susceptibility Testing (EUCAST) criteria (EUCAST breakpoint tables
for the interpretation of MICs and zone diameters, version 5.0, 2015;
http://www.eucast.org). For the analysis, Kp isolates resistant to one
or more carbapenems tested in our institution (i.e. ertapenem,
meropenem and imipenem) were classified as CR-Kp. For blood
CR-Kp isolates, identification of carbapenemase-encoding genes
(blaVIM-, blaIMP-, blaNDM-, blaKPC-) and their variants was also per-
formed by means of PCR as previously described [10].
Statistical analysis
Categorical data are presented as percentages and continuous
data as median and interquartile range. For descriptive purposes,
demographic and clinical characteristics were compared between
patients who developed postoperative CRKP infection and those
who did not. Categorical variables were compared with the χ2test,
whereas continuous variables were compared with the Mann–
Whitney U-test.
The primary study analysis was the identification of variables
associated with the development of postoperative CR-Kp infec-
tion. To this aim, the effect of the aforementioned potential risk
factors was evaluated by means of univariable Cox regression
models, after having verified proportional hazards using the test
based on Schoenfeld residuals implemented in R survival library.
For the purpose of the study, prolonged mechanical ventilation
and CR-Kp colonization were considered as time-dependent vari-
ables, according to the persistence of mechanical ventilation
beyond 48 h after surgery and the time of the first positive rectal
swab, respectively. Because of the exploratory nature of the ana-
lyses, no correction for multiple testing was used, and the signifi-
cance level was set to P < 0.05. To assess the independent role of
variables, a multivariable Cox regression was carried out using a
stepwise backward procedure employing the R algorithm based
on the Akaike information criterion (estimation) at each step. All
time-independent and time-varying variables associated with
CR-Kp infection in univariable analyses (P < 0.10) were included in
the model.
Crude in-hospital mortality was compared between patients
who developed CR-Kp infection and those who did not develop
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180-day mortality according to the development of CR-Kp infec-
tion, a Cox’s proportional hazards model was carried out consid-
ering CR-Kp infection as a time-varying covariate, and the related
survival curve was plotted [11].
The Firth’s correction for monotone likelihood was applied to
all Cox regression models in the present study [12]. All the analyses
were performed using the R Statistical Software (version 3.2.2;
R Foundation for Statistical Computing, Vienna, Austria).
RESULTS
During the study period, 553 patients underwent open heart
surgery at our hospital. Their median age was 71 years [interquar-
tile range (IQR) 64–77] and they were mostly males (379/553,
69%). Thirty-two (6%) developed a postoperative CR-Kp infection,
which occurred at a median time of 22 days after surgery (IQR 13–
34). Observed types of CR-Kp infections are reported in detail in
Table 1. Pneumonia and bloodstream infections (BSIs) accounted
for the majority of events, occurring in as much as 59 and 34% of
the cases, respectively. Among blood CR-Kp isolates, carbapenem
resistance was conferred by the production of KPC-2 and KPC-3
in 2/11 (18%) and 9/11 (82%) cases, respectively.
Table 2 reports the demographic and clinical characteristics of
patients with and without CR-Kp infections. As given in the table,
66 patients (12%) were found to be colonized by CR-Kp. Only five
of them (8%) were already colonized before surgery (in 4 cases col-
onization was known at hospital admission), whereas most of colo-
nized patients acquired CR-Kp in the postoperative period (61/66,
92%), at a median time of 17 days after surgery (IQR 9–30 days). Of
note, preoperative CR-Kp colonization was not considered a
contraindication to surgery. Overall, as many as 31/66 colonized
patients (47%) developed a postoperative CR-Kp infection. Table 3
shows the results of univariable and multivariable Cox regressions
of factors associated with postoperative CR-Kp infection. In univari-
able analyses, female sex, preoperative length of stay, NYHA class,
chronic kidney disease, COPD, preoperative mechanical ventilation,
Charlson comorbidity index, EuroSCORE2, type of surgery, CPB
time, aortic cross-clamp time, need for intraoperative blood trans-
fusion, SOFA score, prolonged mechanical ventilation and CR-Kp
colonization were significantly associated with the development of
CR-Kp infection. The final multivariable model confirmed the fol-
lowing variables as factors associated with the development of
CR-Kp infection: CR-Kp colonization [hazard ratio (HR) 227.45, 95%
confidence intervals (CI) 67.13–1225.20, P < 0.001], CPB time in
minutes (HR 1.01, 95% CI 1.01–1.02, P < 0.001), COPD (HR 3.99,
95% CI 1.61–9.45, P = 0.004), SOFA score (HR 1.29, 95% CI 1.08–
1.53, P = 0.007), preoperative mechanical ventilation (HR 8.10, 95%
CI 1.31–48.57, P = 0.026), prolonged mechanical ventilation (HR
2.48, 95% CI 1.08–6.15, P = 0.032) and female sex (HR 2.08, 95% CI
1.00–4.36, P = 0.049).
The overall crude in-hospital mortality was 25% (8/32) and 6%
(30/521) in patients with and without CR-Kp infection, respective-
ly (P < 0.001), with most deaths in the infection group occurring
within 30 days from the infectious event (6/8, 75%). The recorded
causes of death in patients with CR-Kp infection were multiorgan
failure and respiratory insufficiency in 75% (6/8) and 25% (2/8) of
cases, respectively. After discharge, crude rates of 180-day mortal-
ity among survivors were 25% in patients with postoperative
CR-Kp infection and 4% in those without (6/24 and 19/491,
respectively).
In the Cox regression analysis for 180-day mortality, the devel-
opment of CR-Kp infection was unfavourably associated with the
outcome (HR 11.10, 95% CI 5.81–20.13, P < 0.001). The related
survival curve stratified for CR-Kp infection as a time-varying
factor is shown in Fig. 1.
DISCUSSION
During the observed period, as much as 6% of the patients who
underwent open heart surgery at our hospital developed a post-
operative CR-Kp infection. This percentage dramatically increased
to 47% among CR-Kp colonized patients, who generally acquired
both colonization and subsequent infection in the early post-
operative period. Life-threatening events such as pneumonia and
BSIs accounted for the majority of CR-Kp infections.
A high incidence of postoperative CR-Kp infections was
observed in our cohort, in line with the rates of CR-Kp infections
reported after other major surgical procedures, such as solid
organ transplantations and abdominal surgery in countries and
hospitals where CR-Kp is endemic [6–9]. In the present study,
CR-Kp colonization was an important risk factor for postoperative
CR-Kp infection. This result per se is not surprising. Indeed, al-
though intestinal colonization is not an absolute prerequisite for
infection, the former precedes the latter in most cases [4, 5]. The
major observation stemming from our study is that the rate of
CR-Kp infections among colonized patients was very high, nearly
50%. This rate is far higher than the 8–9% reported among not
homogeneous populations of colonized subjects, whereas it is
similar to that observed by Giannella et al. in colonized patients
after liver transplantation [4, 7, 13]. Although indirectly, these
results strongly confirm the pivotal role of preventive efforts in re-
ducing the incidence of postoperative CR-Kp infections. Indeed,
CR-Kp colonization mostly occurs through interpatient cross-
transmission, which could be dramatically decreased by the rigorous
application of all in-hospital-based infection-control measures (e.g.
systematic screening procedures, rapid patient isolation, mandatory
use of disposable gowns and gloves, dedicated personnel and
devices) [14].
Despite its pre-eminent role, CR-Kp colonization is not the only
risk factor for CR-Kp infections in cardiac surgery. Indeed, we
found that also increased CBP time, COPD, increased SOFA score
at baseline, preoperative mechanical ventilation, prolonged
mechanical ventilation and female sex were significant predictors
of postoperative CR-Kp infection. The association between
increased CPB time and CR-Kp infection might be of interest with
Table 1: Observed types of postoperative carbapenem-
resistant Klebsiella pneumoniae (CR-Kp) infections
Type of infection Total, n (%)
32 (100)
Bloodstream infections 11 (34)
Isolated 6 (19)
With concomitant pneumoniaa 5 (16)
Isolated pneumonia 14 (44)
Surgical wound infections 4 (13)
Urinary tract infection 3 (9)
aCR-Kp mediastinitis was also present in 1 case.
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regard to colonized patients, since CPB-related intestinal ischae-
mia has been recognized to enhance intestinal permeability and
thus bacterial translocation from the intestinal lumen to the
bloodstream [15, 16]. Furthermore, a prolonged CPB time is also
associated with both non-infectious postoperative complications
and an increased utilization of ICU resources (e.g. mechanical ven-
tilation), which increase per se the risk of infection [17]. An
increased utilization of ICU resources predisposing to infections
might also arise from the presence of a severe multiorgan dys-
function at baseline, as testified by the association between an
increased SOFA score immediately after surgery and subsequent
CR-Kp infection in our cohort. The unfavourable impact of co-
morbidities (COPD) and mechanical ventilation on the develop-
ment of bacterial infections has already been described by other
Table 2: Demographic and clinical characteristics of cardiac surgery patients with and without postoperative carbapenem-
resistant Klebsiella pneumoniae (CR-Kp) infections
CR-Kp infection (n = 32) No CR-Kp infection (n = 521) P-value
Demographic
Age (years), median (IQR) 74 (67–77) 71 (63–77) 0.357
Female sex 15 (47) 159 (31) 0.053
BSA (m2), median (IQR) 1.9 (1.7–2.0) 1.8 (1.7–2.0) 0.989
Preoperative and perioperative
Length of preoperative hospital stay (days), median (IQR) 3 (1–6) 2 (1–4) 0.185
NYHA Class 0.132
I 3 (9) 81 (16)
II 8 (25) 183 (35)
III 14 (44) 204 (39)
IV 7 (22) 53 (10)
Hypertension 27 (84) 422 (81) 0.635
Diabetes 8 (25) 122 (23) 0.838
BMI ≥30 kg/m2 7 (22) 72 (14) 0.206
Smoking 10 (31) 227 (44) 0.172
Dyslipidaemia 11 (34) 225 (43) 0.328
Chronic kidney disease 12 (38) 78 (15) <0.001
COPD 10 (31) 62 (12) 0.002
History of immunosuppression 0 (0) 8 (2) 0.499
Extracardiac arteriopathy 11 (34) 91 (17) 0.017
History of cerebrovascular accident 4 (13) 24 (5) 0.048
Previous myocardial infarction 1 (3) 123 (24) 0.007
Charlson comorbidity index, median (IQR) 3 (1–4) 1 (1–2) 0.016
LVEF %, median (IQR) 55 (50–55) 55 (50–60) 0.288
EuroSCORE 2, median (IQR) 8 (4–27) 2 (1–5) <0.001
Preoperative MV 3 (9) 15 (3) 0.044
Complete sternotomy 31 (97) 472 (91) 0.200
Type of surgery <0.001
Isolated coronary artery bypass surgery 4 (13) 194 (37)
Isolated valvular surgery 7 (22) 170 (33)
Surgery of thoracic aorta 13 (41) 68 (13)
Othera 8 (25) 89 (17)
Urgency/emergency 16 (50) 194 (37) 0.150
CPB time (min), median (IQR) 168 (122–232) 102 (76–137) <0.001
Aortic cross-clamp time (min), median (IQR) 100 (69–134) 63 (48–90) <0.001
Need for intraoperative blood transfusion 21 (66) 205 (39) 0.003
SOFA score, median (IQR) 7 (4–9) 4 (3–6) <0.001
Postoperative
Prolonged MV 24 (75) 76 (15) <0.001
Reoperation for bleeding 7 (22) 35 (7) 0.002
Pacemaker implantation 1 (3) 16 (3) 1.000
Postoperative stroke 5 (16) 7 (1) <0.001
Length of postoperative ICU stay (days), median (IQR) 17 (5–23) 1 (1–2) <0.001
Length of postoperative hospital stay (days), median (IQR) 33 (21–54) 8 (6–11) <0.001
CR-Kp colonization
Overall 31 (97) 35 (7) <0.001
Before surgery 2 (6) 3 (1) 0.001
After surgery 29 (91) 32 (6) <0.001
Results are presented as n (%) unless otherwise indicated.
IQR: interquartile range; BSA: body surface area; BMI: body mass index; COPD: chronic obstructive pulmonary disease; NYHA: New York Heart Association;
LVEF: left ventricular ejection fraction; EuroSCORE: European System for Cardiac Operative Risk Evaluation; MV: mechanical ventilation; CPB: cardiopulmonary
bypass; SOFA score: sequential organ failure assessment score; ICU: intensive care unit.



















niversità degli Studi di G
enova user on 01 July 2019
authors [17–19]. Their results, as well as our findings, are in line
with the well-recognized role of such factors in increasing length
of stay and impairing the host immune and mechanical defences,
thereby promoting the development of infection [17, 20].
Finally, while no differences between genders in the risk of
developing CR-Kp infections have been reported so far in other
patient populations, the intriguing association between female sex
and CR-Kp infections in our cohort is consistent with the fact that
women might be at an increased risk of developing bacterial infec-
tions after cardiac surgery, according to some literature data [21].
However, it should be noted that such a gender-related difference
has not been observed in other studies, thus deserving further inves-
tigations [22].
With regard to postoperative outcomes, an in-hospital mortality
as high as 25% was observed in patients who developed
postoperative CR-Kp infections. This is consistent with the high
short-term mortality reported after CR-Kp infections in other
patient populations, conceivably related to the multidrug-resistant
phenotype of CR-Kp [2, 3]. Indeed, it increases the risk of administer-
ing an inactive initial antimicrobial therapy pending strain identifica-
tion, a factor that strongly and unfavourably influences survival [23].
Moreover, even when an active treatment is administered, and
despite its overall benefits on the outcome, a residual impairment of
survival might still result from antimicrobial toxicity in some cases,
since two or three antimicrobials are often used together to increase
the probability of CR-Kp coverage, and to take advantage of syner-
gistic effects [2]. Postoperative CR-Kp infections also affected
180-day survival of our patients. In this regard, it is worth noting that
a reduced mid- and long-term survival has been already reported in
patients recovering from bacterial infections in comparison with
Table 3: Univariable and multivariable analyses of risk factors for postoperative carbapenem-resistant Klebsiella pneumoniae
(CR-Kp) infections in cardiac surgery patients
Variables Univariable analysis Multivariable analysis
Hazard ratio (95% CI) P-value Hazard ratio (95% CI) P-value
Age (years) 1.02 (0.99–1.06) 0.357
Female sex 2.32 (1.19–4.53) 0.014 2.08 (1.00–4.36) 0.049
BSA (m2) 1.62 (0.28–8.64) 0.585






Hypertension 1.26 (0.55–3.52) 0.605
Diabetes 1.05 (0.46–2.18) 0.901
BMI ≥30 kg/m2 2.02 (0.88–4.19) 0.095
Smoking 0.59 (0.16–1.57) 0.321
Dyslipidaemia 0.63 (0.30–1.25) 0.207
Chronic kidney disease 3.87 (1.91–7.56) <0.001
COPD 3.76 (1.79–7.45) <0.001 3.99 (1.61–9.45) 0.004
History of immunosuppression 0.96 (0.01–1.45) 0.977
Extracardiac arteriopathy 1.80 (0.81–3.67) 0.140
History of cerebrovascular accident 2.51 (0.80–6.11) 0.104
Previous myocardial infarction 0.78 (0.30–1.71) 0.553
LVEF 0.98 (0.95–1.02) 0.388
Preoperative MV 5.41 (1.46–14.31) 0.015 8.10 (1.31–48.57) 0.026
Charlson index 1.54 (1.23–1.92) <0.001
EuroSCORE 2 1.07 (1.05–1.09) <0.001
Complete sternotomy 2.76 (0.74–24.57) 0.152
Type of surgery <0.001
Isolated coronary artery bypass surgery 1 (Reference)
Isolated valvular surgery 2.17 (0.72–7.54)
Surgery of thoracic aorta 9.09 (3.40–29.77)
Othera 4.23 (1.40–14.66)
Urgency/emergency 1.77 (0.91–3.45) 0.090
CPB time (min) 1.02 (1.01–1.02) <0.001 1.01 (1.01–1.02) <0.001
Aortic cross-clamp time (min) 1.02 (1.01–1.02) <0.001
Need for intraoperative blood transfusion 2.91 (1.48–5.98) 0.002
SOFA score 1.28 (1.11–1.46) <0.001 1.29 (1.08–1.53) 0.007
Prolonged MVb 11.33 (5.285–27.33) <0.001 2.48 (1.08–6.15) 0.032
CR-Kp colonizationb 447.30 (117.20–4007.39) <0.001 227.45 (67.13–1225.20) <0.001
Death was considered as a right-censoring event (n = 49).
BSA: body surface area; BMI: body mass index; COPD: chronic obstructive pulmonary disease; NYHA: New York Heart Association; LVEF: left ventricular
ejection fraction; EuroSCORE: European System for Cardiac Operative Risk Evaluation; MV: mechanical ventilation; CPB: cardiopulmonary bypass; SOFA score:
Sequential Organ Failure Assessment Score.
aIncluding combined procedures, pericardiectomy and surgery for cardiac tumours.
bTime-dependent variables.
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those without postoperative infections [20]. The nature of this effect
has still to be completely understood, but several potential and non-
mutually exclusive mechanisms have been recognized, including
interactions between infections and comorbidities, occurrence of
infection-related complications, extent of organ damage after infec-
tion, prolonged length of hospital stay (which increase the risk of
both other healthcare-associated infections and non-infectious
complications) and persistent imbalances in the patient’s humoural
response [20]. Although dedicated studies and methods are needed
to adequately weigh any possible additional unfavourable effect of
CR-Kp infections on 180-day postoperative mortality in comparison
with infections due to other bacteria, as well as the contribution of
other important factors influencing mortality (e.g. type and appro-
priateness of antimicrobial therapy, antimicrobial toxicity, severity of
the infection), in our opinion a cautious follow-up of this cohort par-
ticularly within the first 6 months after surgery should be recom-
mended.
This study has some limitations. First, it was a single-centre ex-
perience and possible discrepancies between our hospital and
other centres might result from different patient populations, type
of procedures and screening policies. It should also be noted that
the observed period was limited to 2014. However, no consistent
variations in the referral and/or case-mix of patients occurred in
our hospital over recent years, and the study sample could thus be
assumed to be representative of the overall population undergo-
ing cardiac surgery at our institution. Second, a major limitation of
our study is related to the low number of events in our cohort, a
factor possibly associated with biases in regression analyses [24].
Therefore, further study is needed to confirm our exploratory
findings. Another limitation is that we could not evaluate the pos-
sible association between multisite colonization and infection, as
specimens from non-sterile sites other than rectum were not rou-
tinely collected for screening purposes. Finally, the retrospective
nature of the study prevented us from assessing the degree of ad-
herence to infection–control measures and weighing its impact on
the development of postoperative CR-Kp infections. In this regard,
it should be reported that the rapid diffusion of CR-Kp in our
region has prompted the continuous improvement of our infec-
tion–control measures both during and after the study period (e.g.
adoption of laboratory-based computerized alert systems rapidly
informing clinicians of any microbiological specimen positive for
CR-Kp, institution of antimicrobial stewardship programmes, de-
velopment of dedicated guidelines shared by all the hospitals in
our region, routine audits to improve compliance), as an import-
ant concerted effort to ultimately reduce the important burden of
morbidity and mortality related to CR-Kp [25].
In conclusion, in our cohort, CR-Kp colonization was an important
predictor of CR-Kp infection after cardiac surgery, with most colon-
ization and infections occurring in the early postoperative period.
CR-Kp infection after cardiac surgery significantly affected survival.
Because of the dramatic shortage of dependable therapeutic
options, maximized preventive efforts might be the most effective
strategy to reduce the unfavourable impact of CR-Kp on post-
operative morbidity and mortality and to control dissemination.
Conflict of interest: none reported.
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We read with great interest the article by Salsano et al. on the risk factors for carba-
penem-resistant Klebsiella pneumoniae (CR-Kp) infections following open heart
surgery [1]. Rapid dissemination of CR-Kp and other carbapenemase-producing
Gram-negative bacteria inevitably confronts us with a panoply of controversial issues
regarding the choice of detection methods and therapy in patients postoperatively.
Therefore our aim was to emphasize the importance of meticulous laboratory work-
up and to broaden the discussion by highlighting recently emerged treatment
options.
In the methods section the authors state that the interpretative breakpoints for
evaluating carbapenem resistance were based on the European Committee on
Antimicrobial Susceptibility Testing (EUCAST) criteria, but it has to be emphasized
that certain bacterial isolates that produce carbapenemases are categorized as sus-
ceptible by using these breakpoints and (as recommended by the EUCAST criteria)
should be reported as tested [2]. Therefore the presence or absence of a carbapene-
mase does not in itself influence the categorization of susceptibility, and the EUCAST
critera recommend further carbapenemase detection and characterization for public
health and infection control purposes [2].
Still, the authors do not state whether they confirmed the carbapenemase detec-
tion by one of the commonly employed phenotypic screening methods, since poly-
merase chain reaction (PCR) was used only for blood CR-Kp isolates in this paper.
The modified Hodge test would be the screening method of choice (although it is
not without its sensitivity and specificity issues), while there are also several inhibitor
based tests in various formats that can be employed (such as the combination disk
test or imipenem (IPM)/imipenem-EDTA E-test strips) [3].
Considering a very high rate of CR-Kp infections among colonized patients in this
study (almost 50%) and the ensuing life-threatening infectious events, it would be
interesting to additionally investigate clonal relatedness of these bacterial isolates by
using multilocus sequence typing (MLST) and pulsed-field gel electrophoresis (PFGE)
analysis. The allelic variants that can be determined this way would help to under-
stand the clonal relationship of CR-Kp strains, which is a pivotal step in epidemio-
logical investigation and subsequent control of hospital-onset CR-Kp infections.
Treatment of patients infected with CR-Kp is always troublesome due to multidrug
(and sometimes even pan-drug) resistance phenotype, thus the authors rightly state
that two or three antimicrobials are often used concomitantly in order to increase
the probability of adequate coverage and to take advantage of synergistic effects.
One of such promising approaches is a combined therapy in which, rather surprising-
ly, one of the drugs is always a carbapenem (most appropriately meropenem) admi-
nistered at high doses with an extended infusion to boost its pharmacokinetic and
pharmacodynamic features [4].
Even a more counterintuitive (albeit clinically auspicious) approach is a double-car-
bapenem therapy that was effective in a dozen of patients with CR-Kp [4]. This type
of treatment also shows promise in patients after heart surgery, as it resulted in a
complete recovery of a patient from Italy who underwent aortic prosthesis replace-
ment [5]. It is hypothesized that one of the carbapenem compounds can distract the
carbapenemase enzyme by acting as a suicide inhibitor (akin to clavulanate in amoxi-
cillin-clavulanate combination), hence preserving and allowing the activity of the
other carbapenem drug.
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Mestrovic and Bedenic provided some interesting comments on our article entitled
“Risk factors for carbapenem-resistant Klebsiella pneumoniae infections after open
heart surgery” [1, 2]. Their points mainly concern diagnostic intricacies and anti-
microbial therapy.
With regard to the formers, they emphasize the role of a meticulous diagnostic la-
boratory work-up, since minimum inhibitory concentrations (MICs) for carbapenems
of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-Kp)
might vary markedly across strains. Consequently, some of them remain susceptible
to carbapenems [3], although this is the exception rather than the rule in our centre.
With regard to our study, it should be stressed that it was conceived to investigate
risk factors and prognosis of frank carbapenem resistance as defined by clinical
breakpoints. On the other hand, from an epidemiologic standpoint, we agree that
deeper investigations such as multilocus sequence typing (MLST) and pulsed-field
gel electrophoresis (PFGE) might provide important insights on KPC-Kp diffusion. In
our centre, more than 80% of the strains belong to the pandemic clone sequence
type 258 (ST258), although other clones - mainly ST101 and ST307 - have also been
detected in recent years (personal unpublished data).
The second part of Mestrovic and Bedenic comments deals with antimicrobial
therapy of KPC-Kp infections. In this regard, although combination therapies showed
a possible survival benefit over monotherapy in observational studies, it should be
noted that no randomized clinical trials are currently available to reliably compare
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